Market Closed -
Other stock markets
|
After market 00:59:37 | |||
119.10 USD | -0.03% | 118.82 | -0.23% |
Fiscal Period: January | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 10.92B | 16.68B | 26.91B | 26.97B | 60.92B | |||||
Total Revenues | 10.92B | 16.68B | 26.91B | 26.97B | 60.92B | |||||
Cost of Goods Sold, Total | 4.15B | 6.12B | 9.44B | 11.62B | 16.62B | |||||
Gross Profit | 6.77B | 10.56B | 17.48B | 15.36B | 44.3B | |||||
Selling General & Admin Expenses, Total | 1.09B | 1.91B | 2.17B | 2.44B | 2.65B | |||||
R&D Expenses | 2.83B | 3.92B | 5.27B | 7.34B | 8.68B | |||||
Other Operating Expenses, Total | 3.92B | 5.84B | 7.43B | 9.78B | 11.33B | |||||
Operating Income | 2.85B | 4.72B | 10.04B | 5.58B | 32.97B | |||||
Interest Expense, Total | -52M | -184M | -236M | -262M | -257M | |||||
Interest And Investment Income | 178M | 57M | 29M | 267M | 866M | |||||
Net Interest Expenses | 126M | -127M | -207M | 5M | 609M | |||||
Currency Exchange Gains (Loss) | - | - | 7M | - | - | |||||
Other Non Operating Income (Expenses) | -2M | 4M | - | -3M | -1M | |||||
EBT, Excl. Unusual Items | 2.97B | 4.6B | 9.84B | 5.58B | 33.58B | |||||
Restructuring Charges | - | - | - | - | - | |||||
Merger & Related Restructuring Charges | - | -189M | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | 100M | -45M | 238M | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | - | - | - | -1.35B | - | |||||
EBT, Incl. Unusual Items | 2.97B | 4.41B | 9.94B | 4.18B | 33.82B | |||||
Income Tax Expense | 174M | 77M | 189M | -187M | 4.06B | |||||
Earnings From Continuing Operations | 2.8B | 4.33B | 9.75B | 4.37B | 29.76B | |||||
Net Income to Company | 2.8B | 4.33B | 9.75B | 4.37B | 29.76B | |||||
Net Income - (IS) | 2.8B | 4.33B | 9.75B | 4.37B | 29.76B | |||||
Net Income to Common Incl Extra Items | 2.8B | 4.33B | 9.75B | 4.37B | 29.76B | |||||
Net Income to Common Excl. Extra Items | 2.8B | 4.33B | 9.75B | 4.37B | 29.76B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.11 | 0.18 | 0.39 | 0.18 | 1.21 | |||||
Basic EPS - Continuing Operations | 0.11 | 0.18 | 0.39 | 0.18 | 1.21 | |||||
Basic Weighted Average Shares Outstanding | 24.36B | 24.68B | 24.96B | 24.87B | 24.69B | |||||
Net EPS - Diluted | 0.11 | 0.17 | 0.38 | 0.17 | 1.19 | |||||
Diluted EPS - Continuing Operations | 0.11 | 0.17 | 0.38 | 0.17 | 1.19 | |||||
Diluted Weighted Average Shares Outstanding | 24.72B | 25.12B | 25.35B | 25.07B | 24.94B | |||||
Normalized Basic EPS | 0.08 | 0.12 | 0.25 | 0.14 | 0.85 | |||||
Normalized Diluted EPS | 0.08 | 0.11 | 0.24 | 0.14 | 0.84 | |||||
Dividend Per Share | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |||||
Payout Ratio | 13.95 | 9.12 | 4.09 | 9.11 | 1.33 | |||||
American Depositary Receipts Ratio (ADR) | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | |||||
Supplemental Items | ||||||||||
EBITDA | 3.23B | 5.82B | 11.22B | 7.12B | 34.48B | |||||
EBITA | 2.87B | 5.33B | 10.6B | 6.28B | 33.59B | |||||
EBIT | 2.85B | 4.72B | 10.04B | 5.58B | 32.97B | |||||
EBITDAR | 3.34B | 5.96B | 11.38B | 7.31B | 34.75B | |||||
Effective Tax Rate - (Ratio) | 5.86 | 1.75 | 1.9 | -4.47 | 12 | |||||
Current Domestic Taxes | 69M | 198M | 524M | 1.75B | 6.04B | |||||
Current Foreign Taxes | 87M | 161M | 71M | 228M | 502M | |||||
Total Current Taxes | 156M | 359M | 595M | 1.98B | 6.55B | |||||
Deferred Domestic Taxes | 2M | -246M | -420M | -2.16B | -2.7B | |||||
Deferred Foreign Taxes | 16M | -36M | 14M | 1M | 216M | |||||
Total Deferred Taxes | 18M | -282M | -406M | -2.16B | -2.49B | |||||
Normalized Net Income | 1.86B | 2.87B | 6.15B | 3.49B | 20.99B | |||||
Interest on Long-Term Debt | - | - | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 15M | - | - | - | - | |||||
Selling and Marketing Expenses | - | - | - | - | - | |||||
Research And Development Expense From Footnotes | 2.83B | 3.92B | 5.27B | 7.34B | 8.68B | |||||
Net Rental Expense, Total | 114M | 145M | 168M | 193M | 269M | |||||
Imputed Operating Lease Interest Expense | 20.48M | 41.2M | 32.65M | 33.9M | 47.91M | |||||
Imputed Operating Lease Depreciation | 93.52M | 104M | 135M | 159M | 221M | |||||
Stock-Based Comp., COGS (Total) | 39M | 88M | 141M | 138M | 141M | |||||
Stock-Based Comp., R&D Exp. (Total) | 540M | 860M | 1.3B | 1.89B | 2.53B | |||||
Stock-Based Comp., SG&A Exp. (Total) | 265M | 449M | 565M | 680M | 876M | |||||
Total Stock-Based Compensation | 844M | 1.4B | 2B | 2.71B | 3.55B |